Pharmaceutical market access in emerging markets.pdf

Pharmaceutical market access in emerging markets

Güvenç Koçkaya, Albert Wertheimer

Pharmaceutical Market Access could be defined as achieving the optimal price for a product or service and/or the maximum reimbursement for the approved target population with no restrictions on funding for the medical technology. By the way, Market Access is not only the market authorization, but it also includes overlapping activities like pricing, health technology assessment, formulary, and reimbursement. Market Access is one of the most important activities for pharmaceutical companies and emerging countries represent an important opportunity for launching new products. The Market Access processes in the most important emerging countries in the selected regions are defined in this book with the aim to help local experts, local government officers, headquarter managements, and everyone who want to learn more about healthcare system and health policies pathways of Market Access, mapping and structure of decision makers, challenges and catalyzers for Market Access in the emerging countries.

For pharmaceutical manufacturers participating in pharmaceutical market growth in emerging markets, careful analysis of the structural differences in emerging market pharmaceutical systems is required. For many governments, strategies to ensure consistent access to medicines, vaccines, and health technologies in emerging markets are necessary. While overall trends in emerging markets point to growing opportunities, healthcare access and market growth will remain uneven between countries. To conquer an emerging market. Market leaders are trying hard to enter emerging countries. Mergers and acquisitions help pharma giants take advantage of established local sales and distribution networks.

9.74 MB Dimensione del file
8897419631 ISBN
Pharmaceutical market access in emerging markets.pdf


PC e Mac

Leggi l'eBook subito dopo averlo scaricato tramite "Leggi ora" nel tuo browser o con il software di lettura gratuito Adobe Digital Editions.

iOS & Android

Per tablet e smartphone: la nostra app gratuita tolino reader

eBook Reader

Scarica l'eBook direttamente sul lettore nello store o trasferiscilo con il software gratuito Sony READER PER PC / Mac o Adobe Digital Editions.


Dopo la sincronizzazione automatica, apri l'eBook sul lettore o trasferiscilo manualmente sul tuo dispositivo tolino utilizzando il software gratuito Adobe Digital Editions.

Note correnti

Sofi Voighua

To inform your market access planning, we have compiled a list of 5 access to healthcare best practices for emerging markets and developing countries. ... Pricing: Pharma's Achilles Heel: Overcoming the Price War with Smart Market Access ... Market Access Trends In The US, Europe, And Emerging Markets ... For pharmaceutical manufacturers, success will require increasing flexibility on price and the ...

Mattio Mazio

Feb 20, 2012 ... “The issue our clients face is not market access per se, but the real ... into market access, download eyeforpharma's Pharma Emerging Markets ...

Noels Schulzzi

01/07/2015 · Emerging markets have now overtaken the EU5 economies (Germany, France, Italy, the UK, and Spain) in pharmaceutical spending, with a total market size of USD 281 billion compared with the EU5’s USD 196 billion in 2014. As developed economies continue to constrain or cut healthcare funding, governments in many emerging markets are making healthcare a priority.

Jason Statham

This statistic shows the projected spending on medicines in selected emerging pharmaceutical markets in 2023. Market Access is one of the most important activities for pharmaceutical companies and emerging countries represent an important opportunity for launching new products. It was reported that the Compounded Average Growth Rate (CAGR) was 6.0% in the period 2011-2017, and expected sales exceeding 1.1 trillion USD by 2017 for emerging countries.

Jessica Kolhmann

Learn about pharma market access, and how leaders are rethinking the pharmaceutical supply chain to improve access to medicine in emerging markets. Pharmaceutical Market Access in Emerging Markets: Koçkaya, Güvenç, Wertheimer, Albert: Books.